Back to Search
CAROLE SHEAR, MD
MD
Dermatology Physician
NPI: 1578568887Individual
Specialties, Licenses & Credentials
Dermatology PhysicianPrimary
Dermatology
Code: 207N00000X
140666(NY)25MA03729600(NJ)
Research & Publications (19)
Inhibition of CETP by torcetrapib attenuates the atherogenicity of postprandial TG-rich lipoproteins in type IIB hyperlipidemia.
PMID 17951324·Arterioscler Thromb Vasc Biol·2008
3-trial
The failure of torcetrapib: is there a case for independent preclinical and clinical testing?--correspondence.
PMID 18778194·Expert Opin Pharmacother·2008
8-other
Torcetrapib and carotid intima-media thickness in mixed dyslipidaemia (RADIANCE 2 study): a randomised, double-blind trial.
PMID 17630038·Lancet·2007
4-observational
Aggressive management of obesity in children and young adults: the known challenges and potential opportunities.
PMID 17438536·Clin Pharmacol Ther·2007
8-other
Designs of RADIANCE 1 and 2: carotid ultrasound studies comparing the effects of torcetrapib/atorvastatin with atorvastatin alone on atherosclerosis.
PMID 17407645·Curr Med Res Opin·2007
4-observational
Effect of torcetrapib on carotid atherosclerosis in familial hypercholesterolemia.
PMID 17387131·N Engl J Med·2007
4-observational
Effect of torcetrapib on the progression of coronary atherosclerosis.
PMID 17387129·N Engl J Med·2007
4-observational
Biomarkers in the prevention and treatment of atherosclerosis: need, validation, and future.
PMID 17329547·Pharmacol Rev·2007
6-review
Inhibition of cholesteryl ester transfer protein by torcetrapib modestly increases macrophage cholesterol efflux to HDL.
PMID 17322101·Arterioscler Thromb Vasc Biol·2007
7-preclinical
Effects of torcetrapib in patients at high risk for coronary events.
PMID 17984165·N Engl J Med·2007
4-observational
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels on a background of atorvastatin.
PMID 17084250·J Am Coll Cardiol·2006
4-observational
Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.
PMID 17084249·J Am Coll Cardiol·2006
4-observational
CETP polymorphisms associated with HDL cholesterol may differ from those associated with cardiovascular disease.
PMID 15939053·Atherosclerosis·2005
8-other
Intensive lipid lowering with atorvastatin in patients with stable coronary disease.
PMID 15755765·N Engl J Med·2005
3-trial
Treating to New Targets (TNT) Study: does lowering low-density lipoprotein cholesterol levels below currently recommended guidelines yield incremental clinical benefit?
PMID 14715339·Am J Cardiol·2004
3-trial
Correlation of non-high-density lipoprotein cholesterol with apolipoprotein B: effect of 5 hydroxymethylglutaryl coenzyme A reductase inhibitors on non-high-density lipoprotein cholesterol levels.
PMID 11472705·Am J Cardiol·2001
3-trial
Estimating the consequences of anti-psychotic induced weight gain on health and mortality rate.
PMID 11311931·Psychiatry Res·2001
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 114 E 72ND ST, SUITE B
NEW YORK, NY 10021 - Phone
- (212) 472-2890
Quick Facts
- NPI
- 1578568887
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 2
- Locations
- 1
- Publications
- 19
Are you this provider?
Claim Your Profile